We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+7.48%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$111B
AUM Growth
+$4.45B
Cap. Flow
-$1.78B
Cap. Flow %
-1.61%
Top 10 Hldgs %
29%
Holding
4,480
New
63
Increased
1,265
Reduced
2,421
Closed
236

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$46M
2
PLTR icon
Palantir
PLTR
+$40.3M
3
SW
Smurfit Westrock
SW
+$39.2M
4
DELL icon
Dell
DELL
+$29.2M
5
AVTR icon
Avantor
AVTR
+$27.1M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$97.8M
2
LLY icon
Eli Lilly
LLY
+$58.2M
3
NVDA icon
NVIDIA
NVDA
+$48.6M
4
XOM icon
ExxonMobil
XOM
+$31.3M
5
BAC icon
Bank of America
BAC
+$30.5M

Sector Composition

Rank Sector Weight
1 Technology 30.19%
2 Financials 12.91%
3 Healthcare 11.38%
4 Consumer Discretionary 10.81%
5 Industrials 9.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOUG icon
3726
Douglas Elliman
DOUG
$162M
-40,223
Closed -$69K
ADVNB
3727
DELISTED
Advanta Corp Class B
ADVNB
$3 ﹤0.01%
1,650
ACET icon
3728
Adicet Bio
ACET
$74.7M
-1,301
Closed -$25.2K
ACRS icon
3729
Aclaris Therapeutics
ACRS
$869M
-42,005
Closed -$46.2K
ACWV icon
3730
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.38B
-2,370
Closed -$248K
AHT
3731
Ashford Hospitality Trust
AHT
$21M
-236
Closed -$2.29K
ALLK
3732
DELISTED
Allakos
ALLK
-38,096
Closed -$38.1K
AMLX icon
3733
Amylyx Pharmaceuticals
AMLX
$2.54B
-28,779
Closed -$54.7K
ANGI icon
3734
Angi Inc
ANGI
$196M
-526
Closed -$10.1K
ANTX icon
3735
AN2 Therapeutics
ANTX
$214M
-250
Closed -$537
APYX icon
3736
Apyx Medical
APYX
$171M
-1,284
Closed -$1.72K
ATER icon
3737
Aterian
ATER
$5.37M
-240
Closed -$674
LONA
3738
LeonaBio Inc
LONA
$72.1M
-153
Closed -$4.06K
ATOM icon
3739
Atomera
ATOM
$214M
-11,726
Closed -$44.7K
AXTI icon
3740
AXT Inc
AXTI
$5.8B
-1,871
Closed -$6.32K
BCAB icon
3741
BioAtla
BCAB
$5.74M
-403
Closed -$27.6K
BFLY icon
3742
Butterfly Network
BFLY
$2.35B
-14,190
Closed -$11.9K
BGFV
3743
DELISTED
Big 5 Sporting Goods
BGFV
-11,569
Closed -$34.2K
BHM icon
3744
Bluerock Homes Trust
BHM
$34.9M
-157
Closed -$2.75K
BIVI icon
3745
BioVie
BIVI
$7.54M
-7
Closed -$277
BNGO icon
3746
Bionano Genomics
BNGO
$13.3M
-20
Closed -$832
BRBS icon
3747
Blue Ridge Bankshares
BRBS
$332M
-10,207
Closed -$26.6K
BRLT icon
3748
Brilliant Earth
BRLT
$21.6M
-386
Closed -$856
BTAI icon
3749
BioXcel Therapeutics
BTAI
$27.8M
-719
Closed -$14.7K
BW icon
3750
Babcock & Wilcox
BW
$1.39B
-37,299
Closed -$54.1K

Similar funds

RhumbLine Advisers's Q3 2024 Portfolio in Review

As of Q3 2024, RhumbLine Advisers held 4,480 positions worth $111B, up 4.2% from $106B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

RhumbLine Advisers's Q3 2024 filing shows 63 new, 1,265 increased, 2,421 reduced and 236 closed positions. Its largest new stake was Smurfit Westrock: 860,959 shares worth $42.5M. The largest sale was Microsoft, an estimated $97.8M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q3 2024 buy was Smurfit Westrock: 860,959 shares worth $42.5M.
  • RhumbLine Advisers added most to Apple in Q3 2024, an estimated $46M increase.
  • RhumbLine Advisers's biggest Q3 2024 reduction was Microsoft, cutting an estimated $97.8M.
  • RhumbLine Advisers fully exited Expand Energy Corp in Q3 2024, selling an estimated $27.4M.
  • RhumbLine Advisers's ten largest holdings make up 29% of its $111B portfolio in Q3 2024.
  • RhumbLine Advisers opened 63 new positions and closed 236 in Q3 2024.
  • RhumbLine Advisers's portfolio value rose 4.2% quarter-over-quarter to $111B.

Based on RhumbLine Advisers's 13F filing for Q3 2024, filed 12 Nov 2024.